CME INDIA Presentation by Admin. Original Indian Study (Peer reviewed – Published online on 5th February 2022) It gives a very illuminating learning that despite a higher antibody titre with Covishield, decline was significant at 6-months vs. no decline with Covaxin. It is worth to note that T2DM cohorts had lowest seropositivity, while hypertensive had … Continue reading COVAT Study Unique Findings: Covishield vs Covaxin – Both Doing Great to Protect Mankind